200086304

Novus Biologicals™ DC-SIGN/CD209 Antibody (INSERM patent anti-DC-SIGN) - Humanized, Novus Biologicals™

Human Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

DC-SIGN/CD209

Applications

Flow Cytometry, ELISA, Functional Assay

Conjugate

Unconjugated

Host Species

Human

Research Discipline

Adaptive Immunity, Immunology, Virology Bacteria and Parasites

Formulation

Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)

Gene Alias

CD209 antigendendritic cell-specific intracellular adhesion molecules (ICAM)-3 grabbingnon-integrin, CD209 molecule, CDSIGNHIV gpl20-binding protein, CLEC4LC-type lectin domain family 4 member L, DC-SIGN1C-type lectin domain family 4, member L, DC-SIGNMGC129965, Dendritic cell-specific ICAM-3-grabbing non-integrin 1

Immunogen

DC-SIGN/ CD209

Primary or Secondary

Primary

Reconstitution

Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.

Clone

INSERM patent anti-DC-SIGN

Classification

Monoclonal

Form

Purified

Regulatory Status

RUO

Target Species

Human

Gene Accession No.

Q9NNX6

Gene ID (Entrez)

30835

Isotype

IgG1

Purification Method

Protein A purified

Content And Storage

Store at -20°C in powder form. Store at -80°C once reconstituted.

Description

  • DC-SIGN/CD209 Monoclonal antibody specifically detects DC-SIGN/CD209 in Human samples
  • It is validated for Flow Cytometry,ELISA,Functional Assay